Skip to main content
Top
Published in:

26-12-2023 | Cannabinoid | Original Research Article

Acute Effects of Ad Libitum Use of Commercially Available Cannabis Products on the Subjective Experience of Aerobic Exercise: A Crossover Study

Authors: Laurel P. Gibson, Gregory R. Giordano, L. Cinnamon Bidwell, Kent E. Hutchison, Angela D. Bryan

Published in: Sports Medicine | Issue 4/2024

Login to get access

Abstract

Objective

The present study aimed to examine the acute effects of legal-market cannabis on regular cannabis users’ subjective responses to exercise in a controlled laboratory environment.

Background

Given the stereotype that cannabis is associated with extreme sedentary behavior, there are concerns that cannabis legalization may exacerbate the US physical inactivity epidemic. However, despite these concerns, recent years have seen considerable public interest in the use of cannabis concurrently with exercise (e.g., running).

Methods

The present study compared participants’ experiences of exercise without cannabis to their experiences of exercise after acute ad libitum use of one of two commercially available cannabis flower products: a Δ9-tetrahydrocannabinol-dominant or a cannabidiol-dominant product. Participants (N = 42) were regular cannabis users between the ages of 21 and 39 years (mean = 30.81 years, standard deviation = 4.72 years).

Results

Although participants reported a more positive affect (p < 0.001), enjoyment (p < 0.001), and runner’s high symptoms (p < 0.001) during their cannabis (vs non-cannabis) exercise appointment, they also reported more exertion (p = 0.04). Pain levels were very low and did not differ between appointments (p = 0.45). Effects appeared to depend, in part, on cannabinoid content; there was a larger difference in enjoyment (p = 0.02), and a smaller difference in exertion (p = 0.02), between the cannabis and non-cannabis exercise appointments among participants in the cannabidiol (vs Δ9-tetrahydrocannabinol) condition.

Conclusions

To our knowledge, this is the first study to investigate the acute effects of commercially available cannabis on subjective responses to exercise in a laboratory environment. Our findings suggest that, among regular cannabis users who use cannabis in combination with exercise, cannabis use prior to exercise may lead to increases in both positive and negative aspects of the subjective exercise experience. Research using diverse samples, exercise modalities, and methodologies (e.g., placebo-controlled trials) is needed to establish the generalizability of these findings.
Appendix
Available only for authorised users
Footnotes
1
We began collecting heart rate data midway through the study. As such, heart rate data are only available for 73.8% of participants (n = 31).
 
2
Runner’s high symptoms and RHR were only assessed at one timepoint (runner’s high symptoms: post-exercise; RHR: pre-exercise). As such, these models only included one within-subjects factor (i.e., exercise appointment [cannabis vs. non-cannabis] but not time) and estimated random intercepts (but not slopes) for participant. These models therefore examined (1) average runner’s high symptoms/RHR, (2) the effect of exercise appointment on runner’s high symptoms/RHR, (3) the effect of cannabis condition on runner’s high symptoms/RHR, and (4) the exercise appointment by cannabis condition interaction.
 
Literature
2.
go back to reference Martins SS, Segura LE, Levy NS, Mauro PM, Mauro CM, Philbin MM, et al. Racial and ethnic differences in cannabis use following legalization in US states with medical cannabis laws. JAMA Netw Open. 2021;4(9): e2127002.PubMedPubMedCentralCrossRef Martins SS, Segura LE, Levy NS, Mauro PM, Mauro CM, Philbin MM, et al. Racial and ethnic differences in cannabis use following legalization in US states with medical cannabis laws. JAMA Netw Open. 2021;4(9): e2127002.PubMedPubMedCentralCrossRef
5.
go back to reference Greenway FL, Kirwan JP. Medical marijuana: an obesity problem or opportunity? Int J Obesity. 2019;43(4):761–2.CrossRef Greenway FL, Kirwan JP. Medical marijuana: an obesity problem or opportunity? Int J Obesity. 2019;43(4):761–2.CrossRef
6.
go back to reference Korn L, Haynie DL, Luk JW, Simons-Morton BG. Prospective associations between cannabis use and negative and positive health and social measures among emerging adults. Int J Drug Policy. 2018;58:55–63.PubMedCrossRef Korn L, Haynie DL, Luk JW, Simons-Morton BG. Prospective associations between cannabis use and negative and positive health and social measures among emerging adults. Int J Drug Policy. 2018;58:55–63.PubMedCrossRef
7.
go back to reference Ong LQ, Bellettiere J, Alvarado C, Chavez P, Berardi V. Cannabis use, sedentary behavior, and physical activity in a nationally representative sample of US adults. Harm Reduct J. 2021;18(1):1–10.CrossRef Ong LQ, Bellettiere J, Alvarado C, Chavez P, Berardi V. Cannabis use, sedentary behavior, and physical activity in a nationally representative sample of US adults. Harm Reduct J. 2021;18(1):1–10.CrossRef
8.
go back to reference Smith L, Sherratt F, Barnett Y, Cao C, Tully MA, Koyanagi A, et al. Physical activity, sedentary behaviour and cannabis use in 15,822 US adults: cross-sectional analyses from NHANES. Public Health. 2019;193:76–82.CrossRef Smith L, Sherratt F, Barnett Y, Cao C, Tully MA, Koyanagi A, et al. Physical activity, sedentary behaviour and cannabis use in 15,822 US adults: cross-sectional analyses from NHANES. Public Health. 2019;193:76–82.CrossRef
9.
go back to reference Vidot DC, Bispo JB, Hlaing WM, Prado G, Messiah SE. Moderate and vigorous physical activity patterns among marijuana users: results from the 2007–2014 National Health and Nutrition Examination Surveys. Drug Alcohol Depend. 2017;178:43–8.PubMedCrossRef Vidot DC, Bispo JB, Hlaing WM, Prado G, Messiah SE. Moderate and vigorous physical activity patterns among marijuana users: results from the 2007–2014 National Health and Nutrition Examination Surveys. Drug Alcohol Depend. 2017;178:43–8.PubMedCrossRef
10.
go back to reference York Williams SL, Gust CJ, Mueller R, Bidwell L, Hutchison KE, Gillman AS, et al. The new runner’s high? Examining relationships between cannabis use and exercise behavior in states with legalized cannabis. Front Public Health. 2019;7:99.PubMedCrossRef York Williams SL, Gust CJ, Mueller R, Bidwell L, Hutchison KE, Gillman AS, et al. The new runner’s high? Examining relationships between cannabis use and exercise behavior in states with legalized cannabis. Front Public Health. 2019;7:99.PubMedCrossRef
11.
go back to reference YorkWilliams SL, Gibson LP, Gust CJ, Giordano G, Hutchison KE, Bryan AD. Exercise intervention outcomes with cannabis users and nonusers aged 60 and older. Am J Health Behav. 2020;44(4):420–31.PubMedCrossRef YorkWilliams SL, Gibson LP, Gust CJ, Giordano G, Hutchison KE, Bryan AD. Exercise intervention outcomes with cannabis users and nonusers aged 60 and older. Am J Health Behav. 2020;44(4):420–31.PubMedCrossRef
21.
go back to reference Charron J, Carey V, Roy P, Comtois AS, Ferland PM. Acute effects of cannabis consumption on exercise performance: a systematic and umbrella review. J Sports Med Phys Fitness. 2020;61(4):551–61.PubMed Charron J, Carey V, Roy P, Comtois AS, Ferland PM. Acute effects of cannabis consumption on exercise performance: a systematic and umbrella review. J Sports Med Phys Fitness. 2020;61(4):551–61.PubMed
22.
go back to reference Gillman AS, Hutchison KE, Bryan AD. Cannabis and exercise science: a commentary on existing studies and suggestions for future directions. Sports Med. 2015;45:1357–63.PubMedCrossRef Gillman AS, Hutchison KE, Bryan AD. Cannabis and exercise science: a commentary on existing studies and suggestions for future directions. Sports Med. 2015;45:1357–63.PubMedCrossRef
23.
go back to reference Bird KD, Boleyn T, Chesher GB, Jackson DM, Starmer GA, Teo RKC. Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance. Psychopharmacology. 1980;71:181–8.PubMedCrossRef Bird KD, Boleyn T, Chesher GB, Jackson DM, Starmer GA, Teo RKC. Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance. Psychopharmacology. 1980;71:181–8.PubMedCrossRef
24.
go back to reference Kvålseth TO. Effects of marijuana on human reaction time and motor control. Percept Mot Skills. 1977;45(3):935–9.PubMedCrossRef Kvålseth TO. Effects of marijuana on human reaction time and motor control. Percept Mot Skills. 1977;45(3):935–9.PubMedCrossRef
25.
go back to reference Renaud AM, Cormier YVON. Acute effects of marihuana smoking on maximal exercise performance. Med Sci Sports Exerc. 1986;18(6):685–9.PubMedCrossRef Renaud AM, Cormier YVON. Acute effects of marihuana smoking on maximal exercise performance. Med Sci Sports Exerc. 1986;18(6):685–9.PubMedCrossRef
26.
go back to reference Steadward RD, Singh M. The effects of smoking marihuana on physical performance. Med Sci Sports. 1975;7(4):309–11.PubMed Steadward RD, Singh M. The effects of smoking marihuana on physical performance. Med Sci Sports. 1975;7(4):309–11.PubMed
27.
go back to reference Avakian EV, Horvath SM, Michael ED, Jacobs S. Effect of marihuana on cardiorespiratory responses to submaximal exercise. Clin Pharmacol Ther. 1979;26(6):777–81.PubMedCrossRef Avakian EV, Horvath SM, Michael ED, Jacobs S. Effect of marihuana on cardiorespiratory responses to submaximal exercise. Clin Pharmacol Ther. 1979;26(6):777–81.PubMedCrossRef
28.
go back to reference Ewell TR, Bomar MC, Abbotts KSS, Butterklee HM, Dooley GP, Bell C. Edible marijuana and cycle ergometer exercise. Front Physiol. 2022;13:2552.CrossRef Ewell TR, Bomar MC, Abbotts KSS, Butterklee HM, Dooley GP, Bell C. Edible marijuana and cycle ergometer exercise. Front Physiol. 2022;13:2552.CrossRef
29.
go back to reference Ogle WL, Gold GJ, Coppen LE, Copriviza C. How and why adults use cannabis during physical activity. J Cannabis Res. 2022;4(1):1–10.CrossRef Ogle WL, Gold GJ, Coppen LE, Copriviza C. How and why adults use cannabis during physical activity. J Cannabis Res. 2022;4(1):1–10.CrossRef
31.
go back to reference Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. NeuroReport. 2003;14(17):2209–11.PubMedCrossRef Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. NeuroReport. 2003;14(17):2209–11.PubMedCrossRef
33.
go back to reference Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high.’ J Exp Biol. 2012;215(8):1331–6.PubMedCrossRef Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high.’ J Exp Biol. 2012;215(8):1331–6.PubMedCrossRef
34.
go back to reference Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, Leclair E, et al. Intense exercise increases circulating endocannabinoid and BDNF levels in humans: possible implications for reward and depression. Psychoneuroendocrinology. 2012;37(6):844–51.PubMedCrossRef Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, Leclair E, et al. Intense exercise increases circulating endocannabinoid and BDNF levels in humans: possible implications for reward and depression. Psychoneuroendocrinology. 2012;37(6):844–51.PubMedCrossRef
35.
go back to reference Dishman RK, O’Connor PJ. Lessons in exercise neurobiology: the case of endorphins. Ment Health Phys Activity. 2009;2(1):4–9.CrossRef Dishman RK, O’Connor PJ. Lessons in exercise neurobiology: the case of endorphins. Ment Health Phys Activity. 2009;2(1):4–9.CrossRef
36.
go back to reference Hicks SD, Jacob P, Perez O, Baffuto M, Gagnon Z, Middleton FA. The transcriptional signature of a runner’s high. Med Sci Sports Exerc. 2019;51(5):970–8.PubMedCrossRef Hicks SD, Jacob P, Perez O, Baffuto M, Gagnon Z, Middleton FA. The transcriptional signature of a runner’s high. Med Sci Sports Exerc. 2019;51(5):970–8.PubMedCrossRef
37.
go back to reference Lu HC, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607–15.PubMed Lu HC, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607–15.PubMed
38.
go back to reference Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, et al. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022;27(1): e13092.PubMedCrossRef Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, et al. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022;27(1): e13092.PubMedCrossRef
39.
go back to reference Okey SA, Meier MH. A within-person comparison of the subjective effects of higher vs. lower-potency cannabis. Drug Alcohol Depend. 2020;216: 108225.PubMedCrossRef Okey SA, Meier MH. A within-person comparison of the subjective effects of higher vs. lower-potency cannabis. Drug Alcohol Depend. 2020;216: 108225.PubMedCrossRef
40.
go back to reference Raedeke TD. The relationship between enjoyment and affective responses to exercise. J Appl Sport Psychol. 2007;19(1):105–15.CrossRef Raedeke TD. The relationship between enjoyment and affective responses to exercise. J Appl Sport Psychol. 2007;19(1):105–15.CrossRef
41.
go back to reference Kwan BM, Bryan A. In-task and post-task affective response to exercise: translating exercise intentions into behaviour. Br J Health Psychol. 2010;15(1):115–31.PubMedCrossRef Kwan BM, Bryan A. In-task and post-task affective response to exercise: translating exercise intentions into behaviour. Br J Health Psychol. 2010;15(1):115–31.PubMedCrossRef
42.
go back to reference Abrams DI. The therapeutic effects of cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018;49:7–11.PubMedCrossRef Abrams DI. The therapeutic effects of cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018;49:7–11.PubMedCrossRef
43.
go back to reference Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al. The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009;39(10):1607–16.PubMedCrossRef Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al. The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009;39(10):1607–16.PubMedCrossRef
44.
go back to reference Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Design. 2012;18(32):4966–79.CrossRef Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Design. 2012;18(32):4966–79.CrossRef
45.
go back to reference Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol Clin Exp. 2009;24(7):515–23.CrossRef Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol Clin Exp. 2009;24(7):515–23.CrossRef
46.
go back to reference Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111(2):383–90.PubMedCrossRef Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111(2):383–90.PubMedCrossRef
47.
go back to reference Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–60.PubMedCrossRef Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–60.PubMedCrossRef
48.
go back to reference Linke SE, Gallo LC, Norman GJ. Attrition and adherence rates of sustained vs. intermittent exercise interventions. Ann Behav Med. 2011;42(2):197–209.PubMedCrossRef Linke SE, Gallo LC, Norman GJ. Attrition and adherence rates of sustained vs. intermittent exercise interventions. Ann Behav Med. 2011;42(2):197–209.PubMedCrossRef
49.
go back to reference Persinger R, Foster C, Gibson M, Fater DC, Porcari JP. Consistency of the talk test for exercise prescription. Med Sci Sports Exerc. 2004;36(9):1632–6.PubMed Persinger R, Foster C, Gibson M, Fater DC, Porcari JP. Consistency of the talk test for exercise prescription. Med Sci Sports Exerc. 2004;36(9):1632–6.PubMed
50.
go back to reference Reed JL, Pipe AL. The talk test: a useful tool for prescribing and monitoring exercise intensity. Curr Opin Cardiol. 2014;29(5):475–80.PubMedCrossRef Reed JL, Pipe AL. The talk test: a useful tool for prescribing and monitoring exercise intensity. Curr Opin Cardiol. 2014;29(5):475–80.PubMedCrossRef
51.
go back to reference Foster C, Porcari JP, Anderson J, Paulson M, Smaczny D, Webber H, et al. The talk test as a marker of exercise training intensity. J Cardiopul Rehabil Prev. 2008;28(1):24–30.CrossRef Foster C, Porcari JP, Anderson J, Paulson M, Smaczny D, Webber H, et al. The talk test as a marker of exercise training intensity. J Cardiopul Rehabil Prev. 2008;28(1):24–30.CrossRef
52.
go back to reference Woltmann ML, Foster C, Porcari JP, Camic CL, Dodge C, Haible S, et al. Evidence that the talk test can be used to regulate exercise intensity. J Strength Cond Res. 2015;29(5):1248–54.PubMedCrossRef Woltmann ML, Foster C, Porcari JP, Camic CL, Dodge C, Haible S, et al. Evidence that the talk test can be used to regulate exercise intensity. J Strength Cond Res. 2015;29(5):1248–54.PubMedCrossRef
53.
go back to reference Bidwell LC, Mueller R, York Williams SL, Hagerty S, Bryan AD, Hutchison KE. A novel observational method for assessing acute responses to cannabis: preliminary validation using legal market strains. Cannabis Cannabinoid Res. 2018;3(1):35–44.PubMedPubMedCentralCrossRef Bidwell LC, Mueller R, York Williams SL, Hagerty S, Bryan AD, Hutchison KE. A novel observational method for assessing acute responses to cannabis: preliminary validation using legal market strains. Cannabis Cannabinoid Res. 2018;3(1):35–44.PubMedPubMedCentralCrossRef
54.
go back to reference Gibson LP, Skrzynski CJ, Giordano GR, Bryan AD. A daily diary investigation of cannabis use and its diet and exercise correlates. Front Psychol. 2023;14:1217144.PubMedPubMedCentralCrossRef Gibson LP, Skrzynski CJ, Giordano GR, Bryan AD. A daily diary investigation of cannabis use and its diet and exercise correlates. Front Psychol. 2023;14:1217144.PubMedPubMedCentralCrossRef
55.
go back to reference Klawitter J, Sempio C, Mörlein S, De Bloois E, Klepacki J, Henthorn T, et al. An atmospheric pressure ionization MS/MS assay using online extraction for the analysis of 11 cannabinoids and metabolites in human plasma and urine. Ther Drug Monit. 2017;39(5):556.PubMedPubMedCentralCrossRef Klawitter J, Sempio C, Mörlein S, De Bloois E, Klepacki J, Henthorn T, et al. An atmospheric pressure ionization MS/MS assay using online extraction for the analysis of 11 cannabinoids and metabolites in human plasma and urine. Ther Drug Monit. 2017;39(5):556.PubMedPubMedCentralCrossRef
56.
go back to reference Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–6.PubMed Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–6.PubMed
57.
go back to reference Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O’Malley SS. The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology. 2013;227:177–92.PubMedCrossRef Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O’Malley SS. The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology. 2013;227:177–92.PubMedCrossRef
58.
go back to reference Borg GA. Perceived exertion: a note on “history” and methods. Med Sci Sports Exerc. 1973;5:90–3.CrossRef Borg GA. Perceived exertion: a note on “history” and methods. Med Sci Sports Exerc. 1973;5:90–3.CrossRef
59.
go back to reference Borg G. Borg’s perceived exertion and pain scales. 1st ed. Human Kinetics; 1998. Borg G. Borg’s perceived exertion and pain scales. 1st ed. Human Kinetics; 1998.
60.
go back to reference Hardy CJ, Rejeski WJ. Not what, but how one feels: the measurement of affect during exercise. J Sport Exerc Psychol. 1989;11(3):304–17.CrossRef Hardy CJ, Rejeski WJ. Not what, but how one feels: the measurement of affect during exercise. J Sport Exerc Psychol. 1989;11(3):304–17.CrossRef
61.
go back to reference Svebak S, Murgatroyd S. Metamotivational dominance: a multimethod validation of reversal theory constructs. J Pers Soc Psychol. 1985;48(1):107.CrossRef Svebak S, Murgatroyd S. Metamotivational dominance: a multimethod validation of reversal theory constructs. J Pers Soc Psychol. 1985;48(1):107.CrossRef
62.
go back to reference Gillman AS, Bryan AD. Effects of performance versus game-based mobile applications on response to exercise. Ann Behav Med. 2016;50(1):157–62.PubMedCrossRef Gillman AS, Bryan AD. Effects of performance versus game-based mobile applications on response to exercise. Ann Behav Med. 2016;50(1):157–62.PubMedCrossRef
63.
go back to reference Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.CrossRef Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.CrossRef
64.
go back to reference Sahinovic A, Irwin C, Doohan PT, Kevin RC, Cox AJ, Lau NS, et al. Effects of cannabidiol on exercise physiology and bioenergetics: a randomised controlled pilot trial. Sports Med Open. 2022;8(1):1–8.CrossRef Sahinovic A, Irwin C, Doohan PT, Kevin RC, Cox AJ, Lau NS, et al. Effects of cannabidiol on exercise physiology and bioenergetics: a randomised controlled pilot trial. Sports Med Open. 2022;8(1):1–8.CrossRef
65.
go back to reference Lisano J, Phillips K, Smith J, Barnes M, Stewart L. Patterns and perceptions of cannabis use with physical activity. Cannabis. 2019;2(2):151–64.CrossRef Lisano J, Phillips K, Smith J, Barnes M, Stewart L. Patterns and perceptions of cannabis use with physical activity. Cannabis. 2019;2(2):151–64.CrossRef
66.
go back to reference Bidwell LC, Karoly HC, Torres MO, Master A, Bryan AD, Hutchison KE. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology. 2022;239(2):385–97.PubMedCrossRef Bidwell LC, Karoly HC, Torres MO, Master A, Bryan AD, Hutchison KE. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology. 2022;239(2):385–97.PubMedCrossRef
67.
go back to reference Machado Bergamaschi M, Helena Costa Queiroz R, Waldo Zuardi A, Crippa AS. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011;6(4):237–49.CrossRef Machado Bergamaschi M, Helena Costa Queiroz R, Waldo Zuardi A, Crippa AS. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011;6(4):237–49.CrossRef
68.
go back to reference Bryan AD, Magnan RE, Nilsson R, Marcus BH, Tompkins SA, Hutchison KE. The big picture of individual differences in physical activity behavior change: a transdisciplinary approach. Psychol Sport Exerc. 2011;12(1):20–6.PubMedPubMedCentralCrossRef Bryan AD, Magnan RE, Nilsson R, Marcus BH, Tompkins SA, Hutchison KE. The big picture of individual differences in physical activity behavior change: a transdisciplinary approach. Psychol Sport Exerc. 2011;12(1):20–6.PubMedPubMedCentralCrossRef
69.
go back to reference Gasparini VH, Azevedo P, Carletti L, Perez AJ. Oxygen consumption and heart rate obtained in a ramp protocol are equivalent during exercise session of rectangular loading at ventilatory thresholds for athletes. Rev Bras Cineantropom Desempenho Hum. 2019;21:1–13.CrossRef Gasparini VH, Azevedo P, Carletti L, Perez AJ. Oxygen consumption and heart rate obtained in a ramp protocol are equivalent during exercise session of rectangular loading at ventilatory thresholds for athletes. Rev Bras Cineantropom Desempenho Hum. 2019;21:1–13.CrossRef
70.
go back to reference Weltman A, Weltman J, Rutt R, Seip R, Levine S, Snead D, et al. Percentages of maximal heart rate, heart rate reserve, and VO2peak for determining endurance training intensity in sedentary women. Int J Sports Med. 1989;10(03):212–6.PubMedCrossRef Weltman A, Weltman J, Rutt R, Seip R, Levine S, Snead D, et al. Percentages of maximal heart rate, heart rate reserve, and VO2peak for determining endurance training intensity in sedentary women. Int J Sports Med. 1989;10(03):212–6.PubMedCrossRef
72.
go back to reference Ekkekakis P, Hall EE, Petruzzello SJ. The relationship between exercise intensity and affective responses demystified: to crack the 40-year-old nut, replace the 40-year-old nutcracker! Ann Behavl Med. 2008;35(2):136–49.CrossRef Ekkekakis P, Hall EE, Petruzzello SJ. The relationship between exercise intensity and affective responses demystified: to crack the 40-year-old nut, replace the 40-year-old nutcracker! Ann Behavl Med. 2008;35(2):136–49.CrossRef
73.
go back to reference Mann T, Lamberts RP, Lambert MI. Methods of prescribing relative exercise intensity: physiological and practical considerations. Sports Med. 2013;43:613–25.PubMedCrossRef Mann T, Lamberts RP, Lambert MI. Methods of prescribing relative exercise intensity: physiological and practical considerations. Sports Med. 2013;43:613–25.PubMedCrossRef
75.
76.
go back to reference Martin-Willett R, Helmuth T, Abraha M, Bryan AD, Hitchcock L, Lee K, et al. Validation of a multisubstance online timeline followback assessment. Brain Behav. 2020;10(1): e01486.PubMedCrossRef Martin-Willett R, Helmuth T, Abraha M, Bryan AD, Hitchcock L, Lee K, et al. Validation of a multisubstance online timeline followback assessment. Brain Behav. 2020;10(1): e01486.PubMedCrossRef
78.
go back to reference Heishman SJ, Singleton EG, Liguori A. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction. 2001;96(7):1023–34.PubMedCrossRef Heishman SJ, Singleton EG, Liguori A. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction. 2001;96(7):1023–34.PubMedCrossRef
79.
go back to reference Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.PubMedCrossRef Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.PubMedCrossRef
80.
go back to reference Kiernan M, Schoffman DE, Lee K, Brown SD, Fair JM, Perri MG, et al. The Stanford Leisure-Time Activity Categorical Item (L-Cat): a single categorical item sensitive to physical activity changes in overweight/obese women. Int J Obesity. 2013;37(12):1597–602.CrossRef Kiernan M, Schoffman DE, Lee K, Brown SD, Fair JM, Perri MG, et al. The Stanford Leisure-Time Activity Categorical Item (L-Cat): a single categorical item sensitive to physical activity changes in overweight/obese women. Int J Obesity. 2013;37(12):1597–602.CrossRef
Metadata
Title
Acute Effects of Ad Libitum Use of Commercially Available Cannabis Products on the Subjective Experience of Aerobic Exercise: A Crossover Study
Authors
Laurel P. Gibson
Gregory R. Giordano
L. Cinnamon Bidwell
Kent E. Hutchison
Angela D. Bryan
Publication date
26-12-2023
Publisher
Springer International Publishing
Keyword
Cannabinoid
Published in
Sports Medicine / Issue 4/2024
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-023-01980-4

Other articles of this Issue 4/2024

Sports Medicine 4/2024 Go to the issue